1. Home
  2. ELYM vs ITRN Comparison

ELYM vs ITRN Comparison

Compare ELYM & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELYM
  • ITRN
  • Stock Information
  • Founded
  • ELYM 2018
  • ITRN 1994
  • Country
  • ELYM United States
  • ITRN Israel
  • Employees
  • ELYM N/A
  • ITRN N/A
  • Industry
  • ELYM Biotechnology: Pharmaceutical Preparations
  • ITRN Electronic Components
  • Sector
  • ELYM Health Care
  • ITRN Technology
  • Exchange
  • ELYM Nasdaq
  • ITRN Nasdaq
  • Market Cap
  • ELYM 440.8M
  • ITRN 564.8M
  • IPO Year
  • ELYM 2021
  • ITRN 2005
  • Fundamental
  • Price
  • ELYM $7.39
  • ITRN $27.22
  • Analyst Decision
  • ELYM
  • ITRN
  • Analyst Count
  • ELYM 0
  • ITRN 0
  • Target Price
  • ELYM N/A
  • ITRN N/A
  • AVG Volume (30 Days)
  • ELYM 260.6K
  • ITRN 85.2K
  • Earning Date
  • ELYM 08-14-2024
  • ITRN 08-19-2024
  • Dividend Yield
  • ELYM N/A
  • ITRN 5.73%
  • EPS Growth
  • ELYM N/A
  • ITRN 19.31
  • EPS
  • ELYM N/A
  • ITRN 2.55
  • Revenue
  • ELYM N/A
  • ITRN $328,756,000.00
  • Revenue This Year
  • ELYM N/A
  • ITRN $8.67
  • Revenue Next Year
  • ELYM N/A
  • ITRN $10.47
  • P/E Ratio
  • ELYM N/A
  • ITRN $10.68
  • Revenue Growth
  • ELYM N/A
  • ITRN 6.49
  • 52 Week Low
  • ELYM $2.35
  • ITRN $24.01
  • 52 Week High
  • ELYM $11.55
  • ITRN $30.19
  • Technical
  • Relative Strength Index (RSI)
  • ELYM 57.40
  • ITRN 46.68
  • Support Level
  • ELYM $5.65
  • ITRN $27.54
  • Resistance Level
  • ELYM $7.89
  • ITRN $30.00
  • Average True Range (ATR)
  • ELYM 0.50
  • ITRN 0.73
  • MACD
  • ELYM 0.20
  • ITRN -0.21
  • Stochastic Oscillator
  • ELYM 77.68
  • ITRN 0.89

About ELYM Eliem Therapeutics Inc

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products. The Telematics services segment consists of regionally- based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal advanced locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others.

Share on Social Networks: